Cargando…

Differential Immune Reactivity Pattern of SW48 and SW1116 Colorectal Cancer Cell Lines with Colorectal Cancer Patients Sera

BACKGROUND: Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide. It is also known as the second leading cause of deaths as the early stage detection is not yet available by current methods. So identification of biomarkers can also be functional in early diagnosis and prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghalamfarsa, Ghasem, Hosseini, Seyyed Vahid, Hamidinia, Maryam, Ghaderi, Abbas, Mahmoudi, Mahmoud, Mojtahedi, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309451/
https://www.ncbi.nlm.nih.gov/pubmed/28217651
http://dx.doi.org/10.4103/2277-9175.199264
_version_ 1782507707784232960
author Ghalamfarsa, Ghasem
Hosseini, Seyyed Vahid
Hamidinia, Maryam
Ghaderi, Abbas
Mahmoudi, Mahmoud
Mojtahedi, Zahra
author_facet Ghalamfarsa, Ghasem
Hosseini, Seyyed Vahid
Hamidinia, Maryam
Ghaderi, Abbas
Mahmoudi, Mahmoud
Mojtahedi, Zahra
author_sort Ghalamfarsa, Ghasem
collection PubMed
description BACKGROUND: Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide. It is also known as the second leading cause of deaths as the early stage detection is not yet available by current methods. So identification of biomarkers can also be functional in early diagnosis and prognosis. MATERIALS AND METHODS: We examined sera from 60 CRC patients of different stages as a source of auto-antibody as well as two human CRC cell lines with different invasive capacities (SW48 and SW1116) as the source of antigens. The pattern of immune reactivity in immuneblotting tests between mentioned cell lines and CRC patients’ sera were evaluated by ImageJ software. RESULTS: The Immune reactivity pattern of two cell lines (SW48 and SW1116) with CRC patients’ sera were different in band intensities and the most immune reactivity intensity was observed in SW48 cell lysate with sera from Stage III CRC patients. CONCLUSION: Due to the humoral immune response, sera from Stage III CRC patients contained autoantibodies that demonstrated higher immune reactivity. Moreover, SW48 cell line with high aggressive behavior reacted to CRC patients’ sera with greater intensity compared with less aggressive behavior cell line (SW1116). Therefore, it is required to use other techniques such as two-dimensional electrophoresis and mass spectrometry.
format Online
Article
Text
id pubmed-5309451
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-53094512017-02-17 Differential Immune Reactivity Pattern of SW48 and SW1116 Colorectal Cancer Cell Lines with Colorectal Cancer Patients Sera Ghalamfarsa, Ghasem Hosseini, Seyyed Vahid Hamidinia, Maryam Ghaderi, Abbas Mahmoudi, Mahmoud Mojtahedi, Zahra Adv Biomed Res Original Article BACKGROUND: Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide. It is also known as the second leading cause of deaths as the early stage detection is not yet available by current methods. So identification of biomarkers can also be functional in early diagnosis and prognosis. MATERIALS AND METHODS: We examined sera from 60 CRC patients of different stages as a source of auto-antibody as well as two human CRC cell lines with different invasive capacities (SW48 and SW1116) as the source of antigens. The pattern of immune reactivity in immuneblotting tests between mentioned cell lines and CRC patients’ sera were evaluated by ImageJ software. RESULTS: The Immune reactivity pattern of two cell lines (SW48 and SW1116) with CRC patients’ sera were different in band intensities and the most immune reactivity intensity was observed in SW48 cell lysate with sera from Stage III CRC patients. CONCLUSION: Due to the humoral immune response, sera from Stage III CRC patients contained autoantibodies that demonstrated higher immune reactivity. Moreover, SW48 cell line with high aggressive behavior reacted to CRC patients’ sera with greater intensity compared with less aggressive behavior cell line (SW1116). Therefore, it is required to use other techniques such as two-dimensional electrophoresis and mass spectrometry. Medknow Publications & Media Pvt Ltd 2017-01-31 /pmc/articles/PMC5309451/ /pubmed/28217651 http://dx.doi.org/10.4103/2277-9175.199264 Text en Copyright: © 2017 Advanced Biomedical Research http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Ghalamfarsa, Ghasem
Hosseini, Seyyed Vahid
Hamidinia, Maryam
Ghaderi, Abbas
Mahmoudi, Mahmoud
Mojtahedi, Zahra
Differential Immune Reactivity Pattern of SW48 and SW1116 Colorectal Cancer Cell Lines with Colorectal Cancer Patients Sera
title Differential Immune Reactivity Pattern of SW48 and SW1116 Colorectal Cancer Cell Lines with Colorectal Cancer Patients Sera
title_full Differential Immune Reactivity Pattern of SW48 and SW1116 Colorectal Cancer Cell Lines with Colorectal Cancer Patients Sera
title_fullStr Differential Immune Reactivity Pattern of SW48 and SW1116 Colorectal Cancer Cell Lines with Colorectal Cancer Patients Sera
title_full_unstemmed Differential Immune Reactivity Pattern of SW48 and SW1116 Colorectal Cancer Cell Lines with Colorectal Cancer Patients Sera
title_short Differential Immune Reactivity Pattern of SW48 and SW1116 Colorectal Cancer Cell Lines with Colorectal Cancer Patients Sera
title_sort differential immune reactivity pattern of sw48 and sw1116 colorectal cancer cell lines with colorectal cancer patients sera
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309451/
https://www.ncbi.nlm.nih.gov/pubmed/28217651
http://dx.doi.org/10.4103/2277-9175.199264
work_keys_str_mv AT ghalamfarsaghasem differentialimmunereactivitypatternofsw48andsw1116colorectalcancercelllineswithcolorectalcancerpatientssera
AT hosseiniseyyedvahid differentialimmunereactivitypatternofsw48andsw1116colorectalcancercelllineswithcolorectalcancerpatientssera
AT hamidiniamaryam differentialimmunereactivitypatternofsw48andsw1116colorectalcancercelllineswithcolorectalcancerpatientssera
AT ghaderiabbas differentialimmunereactivitypatternofsw48andsw1116colorectalcancercelllineswithcolorectalcancerpatientssera
AT mahmoudimahmoud differentialimmunereactivitypatternofsw48andsw1116colorectalcancercelllineswithcolorectalcancerpatientssera
AT mojtahedizahra differentialimmunereactivitypatternofsw48andsw1116colorectalcancercelllineswithcolorectalcancerpatientssera